BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

569 related articles for article (PubMed ID: 25908038)

  • 1. Hyponatremia in cancer patients.
    Platania M; Verzoni E; Vitali M
    Tumori; 2015; 101(2):246-8. PubMed ID: 25908038
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis and management of hyponatremia in cancer patients.
    Castillo JJ; Vincent M; Justice E
    Oncologist; 2012; 17(6):756-65. PubMed ID: 22618570
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of euvolemic hyponatremia attributed to SIADH in the hospital setting.
    Peri A; Giuliani C
    Minerva Endocrinol; 2014 Mar; 39(1):33-41. PubMed ID: 24513602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oncological emergencies: syndrome of inappropriate antidiuretic hormone secretion (SIADH).
    Matwiejczuk S; Püsküllüoğlu M; Zygulska AL
    Przegl Lek; 2014; 71(10):541-3. PubMed ID: 25826978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe paraneoplastic hyponatremia and hypoosmolality in a patient with small-cell lung carcinoma: syndrome of inappropriate antidiuretic hormone secretion versus atrial natriuretic peptide or both?
    Radulescu D; Bunea D; Pripon S; Duncea C; Radulescu L
    Clin Lung Cancer; 2007 May; 8(6):392-5. PubMed ID: 17562242
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Syndrome of inadequate ADH secretion: pitfalls in diagnosis and therapy].
    Schäffler A; Lindner U
    Dtsch Med Wochenschr; 2015 Mar; 140(5):343-6. PubMed ID: 25734677
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tolvaptan use in cancer patients with hyponatremia due to the syndrome of inappropriate antidiuretic hormone: a post hoc analysis of the SALT-1 and SALT-2 trials.
    Gralla RJ; Ahmad F; Blais JD; Chiodo J; Zhou W; Glaser LA; Czerwiec FS
    Cancer Med; 2017 Apr; 6(4):723-729. PubMed ID: 28251822
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical practice. The syndrome of inappropriate antidiuresis.
    Ellison DH; Berl T
    N Engl J Med; 2007 May; 356(20):2064-72. PubMed ID: 17507705
    [No Abstract]   [Full Text] [Related]  

  • 9. [Etiology, diagnostics and therapy of hyponatremias].
    Laczi F
    Orv Hetil; 2008 Jul; 149(29):1347-54. PubMed ID: 18617466
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.
    Gross AJ; Steinberg SM; Reilly JG; Bliss DP; Brennan J; Le PT; Simmons A; Phelps R; Mulshine JL; Ihde DC
    Cancer Res; 1993 Jan; 53(1):67-74. PubMed ID: 8380126
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Current considerations in syndrome of inappropriate secretion of antidiuretic hormone/syndrome of inappropriate antidiuresis].
    Velasco Cano MV; Runkle de la Vega I
    Endocrinol Nutr; 2010 May; 57 Suppl 2():22-9. PubMed ID: 21130959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hyponatremia in the postoperative craniofacial pediatric patient population: a connection to cerebral salt wasting syndrome and management of the disorder.
    Levine JP; Stelnicki E; Weiner HL; Bradley JP; McCarthy JG
    Plast Reconstr Surg; 2001 Nov; 108(6):1501-8. PubMed ID: 11711918
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Vasopressin antagonists in treatment of hyponatremia].
    Olszewski W; Głuszek J
    Pol Arch Med Wewn; 2007 Aug; 117(8):356-62. PubMed ID: 18018383
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 'Dos and don'ts' in the management of hyponatremia.
    Aylwin S; Burst V; Peri A; Runkle I; Thatcher N
    Curr Med Res Opin; 2015; 31(9):1755-61. PubMed ID: 26173050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of arginine vasopressin in the syndrome of inappropriate antidiuresis.
    Robertson GL
    Am J Med; 2006 Jul; 119(7 Suppl 1):S36-42. PubMed ID: 16843083
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel vasopressin dual V1A/V2 receptor antagonist, conivaptan hydrochloride, improves hyponatremia in rats with syndrome of inappropriate secretion of antidiuretic hormone (SIADH).
    Wada K; Matsukawa U; Fujimori A; Arai Y; Sudoh K; Sasamata M; Miyata K
    Biol Pharm Bull; 2007 Jan; 30(1):91-5. PubMed ID: 17202666
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of hyponatremia: role of vaptans].
    Hensen J
    Internist (Berl); 2010 Dec; 51(12):1499-509. PubMed ID: 21104220
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hyponatremia : The water-intolerant patient].
    Hensen J
    Med Klin Intensivmed Notfmed; 2012 Sep; 107(6):440-7. PubMed ID: 22911166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hyponatremia induced by the syndrome of Inappropriate antidiuretic hormone secretion: a multidisciplinary spanish algorithm.
    Runkle I; Villabona C; Navarro A; Pose A; Formiga F; Tejedor A; Poch E
    Nefrologia; 2014; 34(4):439-50. PubMed ID: 25036057
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rapidity of Correction of Hyponatremia Due to Syndrome of Inappropriate Secretion of Antidiuretic Hormone Following Tolvaptan.
    Morris JH; Bohm NM; Nemecek BD; Crawford R; Kelley D; Bhasin B; Nietert PJ; Velez JCQ
    Am J Kidney Dis; 2018 Jun; 71(6):772-782. PubMed ID: 29478867
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.